Private practice with Dr Seth BilazarianView all posts »
Adopting the CHA2DS2-VASc score. Or not.Oct 22, 2010 13:45 EDT
The first Europe-specific guidance on AF was issued recently. It differs from preexisting guidelines by referring more patients to anticoagulation therapy by assigning higher CHA2DS2-VASc risk scores to women over 65 years and all patients over 75 years and seems to anticipate an era of more anticoagulation agents.
Do you use the CHA2DS2-VASc score? Should US-based physicians pay heed to foreign guidelines?